Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-690514 in Pre-treated NSCLC
NCT01167244Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Aug 2010
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BMS-690514 in non-small cell lung carcinoma (NSCLC), sponsored by Bristol Myers Squibb. Started Aug 2010; status: completed.
02
Drugs
BMS-690514
03
Conditions
non-small cell lung carcinoma (NSCLC)
Beyond the preview
Go deeper on NCT01167244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01167244.